MedTrace Logo

Vitamin D Supplementation in Patients With COPD

NCT02122627 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 158

Last updated 2019-09-10

No results posted yet for this study

Summary

Vitamin D has an immunomodulatory role. the aim of the present study is to assess the effect of vitamin D supplementation on exacerbation rate of COPD patient with a vitamin D deficiency.

Conditions

Interventions

DRUG

Vitamin D

Colecalciferol 16.800 IU per week

DRUG

Placebo

Sponsors & Collaborators

  • Leiden University Medical Center

    collaborator OTHER

  • Radboud University Medical Center

    collaborator OTHER

  • Amsterdam UMC, location VUmc

    lead OTHER

Principal Investigators

  • Martin den Heijer, Prof · Amsterdam UMC, location VUmc

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-10
Primary Completion
2019-06-26
Completion
2019-06-26

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02122627 on ClinicalTrials.gov